102 related articles for article (PubMed ID: 4796782)
1. Effect of acute administration of L-dopa on serum concentrations of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in patients with the amenorrhea-galactorrhea syndrome.
Zárate A; Canales ES; Soria J; Maneiro PJ; MacGregor C
Neuroendocrinology; 1973; 12(6):362-5. PubMed ID: 4796782
[No Abstract] [Full Text] [Related]
2. Restoration of ovarian function in patients with the amenorrhea-galactorrhea syndrome after long-term therapy with L-dopa.
Zárate A; Canales ES; Jacobs LS; Maneiro PJ; Soria J; Daughaday WH
Fertil Steril; 1973 May; 24(5):340-4. PubMed ID: 4735421
[No Abstract] [Full Text] [Related]
3. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
Mroueh AM; Siler-Khodr TM
Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
[TBL] [Abstract][Full Text] [Related]
4. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
Seki K; Seki M; Okumura T
Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
[TBL] [Abstract][Full Text] [Related]
5. Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine.
Zárate A; Jacobs LS; Canales ES; Schally AV; De la Cruz A; Soria J; Daughaday WH
J Clin Endocrinol Metab; 1973 Dec; 37(6):855-9. PubMed ID: 4584924
[No Abstract] [Full Text] [Related]
6. Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa.
Turkington RW
J Clin Endocrinol Metab; 1972 Feb; 34(2):306-11. PubMed ID: 5062099
[No Abstract] [Full Text] [Related]
7. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
Lloyd SJ; Josimovich JB; Archer DF
Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of prolactin secretion and successful therapy of the Forbes-Albright syndrome with L-dopa.
Turkington RW; Gordon ES
J Lab Clin Med; 1971 Nov; 78(5):824-5. PubMed ID: 5166936
[No Abstract] [Full Text] [Related]
9. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
[TBL] [Abstract][Full Text] [Related]
10. Galactorrhea-amenorrhea due to primary hypothyroidism.
Boroditsky RS; Faiman C
Am J Obstet Gynecol; 1973 Jul; 116(5):661-5. PubMed ID: 4713129
[No Abstract] [Full Text] [Related]
11. Post-pill and pill-related amenorrhea-galactorrhea.
Gambrell RD; Greenblatt RB; Mahesh VB
Am J Obstet Gynecol; 1971 Jul; 110(6):838-48. PubMed ID: 5562004
[No Abstract] [Full Text] [Related]
12. [FSH and LH plasma levels and their reaction to clomiphene in 3 cases of amenorrhea-galactorrhea syndrome].
Netter A; Gorins A; Franchimont P; Millet D
Ann Endocrinol (Paris); 1972; 33(1):53-63. PubMed ID: 4676410
[No Abstract] [Full Text] [Related]
13. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
Dickey RP; Stone SC
Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
[TBL] [Abstract][Full Text] [Related]
14. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
[TBL] [Abstract][Full Text] [Related]
15. [Endocrine effect of L-DOPA in treating the amenorrhea-galactorrhea syndrome].
Koreneva GP; Shikaeva FV
Probl Endokrinol (Mosk); 1980; 26(6):25-8. PubMed ID: 7192862
[TBL] [Abstract][Full Text] [Related]
16. Clinical uses of multiple serum FSH and LH measurements in patients with amenorrhea and infertility.
Friedman S
Obstet Gynecol; 1973 Jun; 41(6):809-17. PubMed ID: 4736128
[No Abstract] [Full Text] [Related]
17. [The values of prelactin, FSH and LH in the course of galactorrhoea (author's transl)].
Stehlíková J; Talas M; Fingerová H
Cesk Gynekol; 1975 Sep; 40(8):603-5. PubMed ID: 1238174
[No Abstract] [Full Text] [Related]
18. Effect of L-dopa on galactopoiesis and gonadotropin levels in the inappropriate lactation syndrome.
Ayalon D; Peyser MR; Toaff R; Cordova T; Harell A; Franchimont P; Lindner HR
Obstet Gynecol; 1974 Aug; 44(2):159-70. PubMed ID: 4418555
[No Abstract] [Full Text] [Related]
19. Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhoea.
Beumont P; Bruwer J; Pimstone B; Vinik A; Utian W
Br J Psychiatry; 1975 Mar; 126():285-8. PubMed ID: 236061
[No Abstract] [Full Text] [Related]
20. [Response to the treatment of non-puerperal galactorrhea with dihydroergotoxine (author's transl)].
Zielinski de Jakubowicz D; Obregón O
Acta Cient Venez; 1979; 30(1):98-104. PubMed ID: 121905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
